Daily News Podcast

Enteral therapy can reverse Crohn’s disease

Publish date: February 25, 2019

 

Consider enteral therapy in Crohn’s disease, with caveats. A lawsuit against ABIM draws $200,000 in donation support. A combination model predicts imminent preeclampsia. And the FDA wants more safety data on 12 sunscreen active ingredients.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Complementary and alternative medicine
MDedge Endocrinology
Diagnostic metal rod, eyeball extramission, fungal foot fetish
MDedge Endocrinology
The size of the baby boomers’ hepatitis C problem
MDedge Endocrinology
Health spending: Boomers will spike costs, but growing uninsured will soften their impact
MDedge Endocrinology
Parental leave inequities: Kirti Magudia and Thomas Ng, Part I
MDedge Endocrinology
FDA clears first-of-its-kind phone app for insulin management
MDedge Endocrinology
Good news on antipsychotics and birth defects
MDedge Endocrinology
Lawsuit against ABIM draws $200,000 in donation support
MDedge Endocrinology
Final ‘Vision’ report addresses MOC woes
MDedge Endocrinology
Physician PAC dollars support candidates against gun regulation
MDedge Endocrinology